Picture of Palvella Therapeutics logo

PVLA — Palvella Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Pieris Pharmaceuticals Reports Q1 Results

May 10 (Reuters) - Pieris Pharmaceuticals Inc  PIRS.O :
    * PIERIS PHARMACEUTICALS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND BUSINESS UPDATES
    * PIERIS PHARMACEUTICALS INC - CASH, CASH EQUIVALENTS, AND
INVESTMENTS TOTALED $48.4 MILLION FOR THE QUARTER ENDED MARCH
31, 2023
    * PIERIS PHARMACEUTICALS INC - BELIEVES OPERATIONS ARE
SUFFICIENTLY FUNDED FOR MORE THAN THE NEXT 12 MONTHS
    * PIERIS PHARMACEUTICALS INC- QTRLY LOSS PER SHARE $0.45

Source text for Eikon:  ID: 
Further company coverage:  PIRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Palvella Therapeutics

See all news